First Busey (BUSE) CFO Receives 21,395 Restricted Stock Units

Rhea-AI Filing Summary

Insider grant of restricted stock units to CFO

Form 4 shows Christopher H.M. Chan, Chief Financial Officer and reporting person at First Busey Corp (BUSE), received a grant of 21,395 restricted stock units on 10/08/2025. The award was reported as an acquisition at a $0 per-share price and is described as vesting on the third anniversary of the grant date, meaning the units become payable around 10/08/2028 if vesting conditions are met. The filing was signed by an attorney-in-fact on 10/10/2025. No derivative transactions or cash purchases are reported.

Positive

• Retention-focused award: 21,395 RSUs vesting on the third anniversary supports executive retention
• Alignment with shareholders: time-based equity ties CFO incentives to long-term equity performance

Negative

• Potential dilution: issuance of 21,395 RSUs will increase outstanding equity upon settlement
• Limited detail on conditions: filing specifies time-based vesting but does not disclose performance or forfeiture details

Insights

Compensation Analyst

Grant aligns executive pay with long-term retention through time-based RSUs.

The award of 21,395 restricted stock units is a time‑based equity grant that vests on the third anniversary of the grant, tying value realization to continued service rather than immediate cash payout. This structure supports retention and aligns the CFO's incentives with shareholder equity performance over a multi-year horizon.

Key dependencies include continued employment and any standard forfeiture conditions; there is no cash exercise, and the filing lists the acquisition at $0 which reflects a compensation grant rather than a market purchase. Monitor equity dilution and total outstanding RSUs in upcoming proxy or 10‑K disclosures within the next 12 months.

Corporate Governance Specialist

Routine disclosure under Section 16 with clear vesting schedule and signatory attestation.

The Form 4 properly reports the transaction date of 10/08/2025 and includes a statement that the RSUs vest on the third anniversary, satisfying Section 16 reporting requirements for officer compensation events. The signature by an attorney‑in‑fact on 10/10/2025 documents timely filing practice.

Risks are administrative: ensure the proxy/compensation discussion in forthcoming filings discloses aggregate awards and potential acceleration clauses if present. Expect related summary compensation details in the next annual proxy statement.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Chan Christopher H.M.

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	21,395	$0.00	--

Holdings After Transaction: Common Stock — 21,395 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chan Christopher H.M.

(Last) (First) (Middle)

11440 TOMAHAWK CREEK PARKWAY

(Street)

LEAWOOD KS 66211

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
FIRST BUSEY CORP /NV/ [ BUSE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
10/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/08/2025		A		21,395(1)	A	$0	21,395	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant by the Board of Directors of Restricted Stock Units which vest on the third anniversary of the grant date.

Remarks:

	/s/ Carolyn Slattery, attorney-in-fact	10/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Christopher Chan report on the Form 4 for BUSE?

He reported receipt of 21,395 restricted stock units acquired on 10/08/2025 that vest on the third anniversary of the grant.

When do the RSUs reported for BUSE vest?

The filing states the RSUs vest on the third anniversary of the grant date (around 10/08/2028 if standard calendar years apply).

Was there a purchase price for the reported securities on the Form 4?

No cash purchase was reported; the transaction is listed at a price of $0, indicating a compensation grant.

Does the Form 4 show any option exercises or derivative transactions for BUSE?

No. Table II for derivative securities shows no reported transactions; only the non-derivative RSU grant is listed.

Who signed the Form 4 and when was it filed?

The Form 4 was signed by an attorney-in-fact, Carolyn Slattery, on 10/10/2025.